SEARCH

SEARCH BY CITATION

References

  • 1
    Giembycz MA, Lindsay MA. Pharmacology of the eosinophil. Pharmacol Rev 1999;51: 213336.
  • 2
    Rothenberg ME, Mishra A, Brandt EB, Hogan SP. Gastrointestinal eosinophils. Immunol Rev 2003;14: 99111.
  • 3
    Bochner BS, Schleimer RP. Mast cells, basophils and eosinophils: distinct but overlapping pathways for recruitment. Immunol Rev 2001;179: 515.
  • 4
    Broide D, Sriramarao P. Eosinophil trafficking to sites of allergic inflammation. Immunol Rev 2001;179: 163172.
  • 5
    Gleich GJ. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000;105: 651663.
  • 6
    Simon HU. Integrin expression by eosinophils. Allergy 2000;55: 791792.
  • 7
    Behm CA, Ovington KS. The role of eosinophils in parasite helminth infections: insights from genetically modified mice. Parasitol Today 2000;16: 202209.
  • 8
    Meeusen ENT, Balie A. Do eosinophils have a role in the killing of helminth parasites? Parasitol Today 2000;16: 95101.
  • 9
    Lee NA, Gelfand EW, Lee JJ. Pulmonary T cells and eosinophils: coconspirators or independent triggers of allergic respiratory pathology. J Allergy Clin Immunol 2001;107: 945957.
  • 10
    Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344: 350362.
  • 11
    Louis R, Sele J, Henket M, Cataldo D, Bettiol J, Seiden L et al. Sputum eosinophilcount in large population of patients with mild to moderate steroid-naïve asthma distribution and relationship with methancholine bronchial hyperresponsiveness. Allergy 2002;57: 907912.
  • 12
    Bousquet J, Chanez P, Yves Lacoste J, Barneon G, Ghavanian N, Enander I et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323: 10331039.
  • 13
    Rosenberg HF, Damachowske JB. Eosinophils eosinophil ribonucleases and their role in host defense against respiratory virus pathogens. J Leukoc Biol 2001;70: 691698.
  • 14
    Zheutlin LM, Ackerman SJ, Gleich GJ, Thomas LL. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol 1984;133: 21802185.
  • 15
    Henderson WR, Chi EY, Jong EC, Klebanoff SJ. Mast cell-mediated tumor-cell cytotoxicity. Role of the peroxidase system. J Exp Med 1981;153: 520533.
  • 16
    Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Eosinophils activate mast cells to release histamine. Int Arch Allergy Immunol 1999;118: 202203.
  • 17
    Piliponsky AM, Pickholtz D, Gleich GJ, Levi-Schaffer F. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in the late phase allergic reactions. J Allergy Clin Immunol 2001;107: 9931000.
  • 18
    Okayama Y, El-Lati SG, Leiferman KM, Church MK. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J Allergy Clin Immunol 1994;93: 900909.
  • 19
    Patella V, de Crescenzo G, Marino I, Genovese A, Adt M, Gleich GJ et al. Eosinophil granule proteins activate human heart mast cells. J Immunol 1996;157: 12191225.
  • 20
    Patella V, de Crescenzo G, Marino I, Genovese A, Adt M, Gleich GJ et al. Eosinophil granule proteins are selective activators of human mast cells. Int Arch Allergy Immunol 1997;113: 200202.
  • 21
    Piliponsky AM, Gleich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE-dependent activation of human lung and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 2003;101: 18981904.
  • 22
    Tsai M, Takeishi T, Thompson H, Langley KE, Zsebo KM, Metcalfe DD et al. Induction of mast cell proliferation maturation and heparin synthesis by the rat c-kit ligand stem cell factor. Proc Natl Acad Sci USA 1991;88: 63826386.
  • 23
    Iemura A, Tsai M, Ando A, Wershil BK, Galli SJ. The c-kit ligand stem cell factor promotes mast cell survival by suppressing apoptosis. Am J Pathol 1994;144: 321328.
  • 24
    Columbo M, Horowitz EM, Botana LM, Macglashan DW Jr., Bochner BS, Gillis S et al. The human recombinant c-kit receptor ligand rhSCF induces mediator release from human cutaneous mast cells and peripheral blood basophils. J Immunol 1992;149: 599608.
  • 25
    Bischoff SC, Dahinden CA. c-kit ligand a unique potentiator of mediator release by human lung mast cells. J Exp Med 1992;175: 237244.
  • 26
    Bischoff SC, Schwenberg S, Raab R, Manns MP. Functional properties of human intestinal mast cells cultured in a new culture system: enhancement of IgE receptor-dependent mediator release and response to stem cell factor. J Immunol 1997;159: 55605567.
  • 27
    Hartman ML, Piliponsky AM, Temkin V, Levi-Schaffer F. Human peripheral blood eosinophils express stem cell factor. Blood 2001;97: 10861091.
  • 28
    Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neutrophins and secrete nerve growth factor on immunologic stimuli. Blood 2002;99: 22142220.
  • 29
    Horigome K, Bullock ED, Johnson EM Jr. Effects of nerve growth factor on rat peritoneal mast cells survival promotion and immediate-early gene induction. J Biol Chem 1994;269: 26952702.
  • 30
    Smith SJ, Levi-Schaffer F. Mast cell eosinophil-fibroblast cross-talk in allergic inflammation. In: Robinson DS, editor. Asthma and allergic diseases. London: Karger Press, 2000: 8192.
  • 31
    Mauch C, Krieg T. Fibroblast–matrix interactions and their role in the pathogenesis of fibrosis. Rheum Dis Clin North Am 1990;16: 93107.
  • 32
    Hernnas J, Sarnstrand B, Lindroth P, Perterson CG, Venge P, Malmstorm A. Eosinophils cationic protein alters proteoglycan metabolism in human lung fibroblast cultures. Eur J Cell Biol 1992;59: 352363.
  • 33
    Rochester CL, Ackerman SS, Zheng T, Elias JA. Eosinophil fibroblast interactions granule major basic protein interacts with interleukin 1 and transforming growth factor-β in the stimulation of lung fibroblast interleukin 6-type cytokine production. J Immunol 1996;156: 44494456.
  • 34
    Levi-Schaffer F, Garbuzenko E, Rubin A, Reich R, Pickholtz D, Gillery P et al. Human eosinophils regulate human lung and skin-derived fibroblast properties in vitro: a role for transforming growth factor-β. Proc Natl Acad Sci USA 1999;96: 96609665.
  • 35
    Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor basic fibroblast growth factor and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107: 295301.
  • 36
    Solomon A, Aloe L, Pe'er J, Frucht-Pery J, Bonini S, Levi-Schaffer F. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immuol 1998;102: 454460.
  • 37
    Horiuchi T, Weller P. Expression of vascular endothelial growth factor by human eosinophils: upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am J Respir Cell Mol Biol 1997;17: 7077.
  • 38
    Doucet C, Brouty-Boye D, Pottin-C C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts: implication in asthma. J Clin Invest 1998;101: 21292139.
  • 39
    Richter A, Puddicombe SM, Lordan JL, Bucchieri F, Wilson SJ, Djukanovic R et al. The contribution of interleukin (IL) 4 and IL-13 to the epithelial–mesenchymal trophic unit in asthma. Am J Respir Cell Mol Biol 2001;25: 385391.
  • 40
    Simon P, Ying S, Wangoo A, Yee-Ean O, Levi-Schaffer F, Kay BA. The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin. J Immunol 2002;169: 46044612.
  • 41
    Schwingshackl A, Duszyk M, Brown N, Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha. J Allergy Clin Immunol 1999;104: 983989.
  • 42
    Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107: 295301.
  • 43
    Leonardi A, Brun P, Tavolato M, Abatangelo G, Plebani M, Secchi AG. Growth factors and collagen distribution in vernal keratoconjuctivitis. Invest Ophthalmol Vis Sci 2000;41: 41754181.
  • 44
    Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107: 295301.
  • 45
    Kramer MF, Rasp G. Nasal polyposis eosinophils and interleukin 5. Allergy 1999;54: 669680.
  • 46
    Puxeddu I, Alian A, Piliponsky AM, Panet A, Levi-Schaffer F. Modulatory role of human blood eosinophils in angiogenesis: ex vivo and in vitro studies. J Allergy Clin Immunol 2003;111: S211.
  • 47
    Temkin V, Aingorn H, Goldshmidt O, Gleich GJ, Vlodavsky I, Levi-Schaffer F. Heparanase is contained in human peripheral blood eosinophils and its activity is inhibited by eosinophil granule basic proteins. J Allergy Clin Immunol 2003;111: S258.
  • 48
    Vlodavski I, Friedman Y. Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest 2001;108: 341347.
  • 49
    Samoszuk M. Eosinophils and human cancer. Histol Histopathol 1997;12: 807812.
  • 50
    Rivoltini L, Viggiano V, Spinazze S, Santoro A, Colombo MP, Takatsu K et al. In vitro antitumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Int J Cancer 1993;54: 815.
  • 51
    Fernandez-Acenero MJ, Galindo-Gallego M, Sanz J, Aljama A. Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma. Cancer 2000;88: 15441548.
  • 52
    Roberts RL, Bonnie JA, Stiehm ER. Human eosinophils are more toxic than neutrophils in antibody-independent killing. J Allergy Clin Immunol 1991;87: 11051115.
  • 53
    Nathan CF, Klebanoff SJ. Augmentation of spontaneous macrophage-mediated cytolysis by eosinophil peroxidase. J Exp Med 1982;155: 12911308.
  • 54
    Van Der Vliet A, Eistrich JP, Haliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite a potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem 1997;272: 76177625.
  • 55
    Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H. The central role of CD4+ T cells in the antitumor immune response. J Exp Med 1998;188: 23572368.
  • 56
    Mattes J, Hulett M, Xie W, Hogan S, Rothenberg ME, Foster P et al. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT 6-dependent process. J Exp Med 2003;197: 387393.
  • 57
    Ravetch JV, Lanier LL. Immune inhibitory receptors. Science 2000;290: 8489.
  • 58
    Colonna M, Nakajima H, Navarro F, Lopez-Botet M. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells. J Leukoc Biol 1999;66: 375381.
  • 59
    Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol 2003;6: 445453.
  • 60
    Tedla N, Banderia-Melo C, Tassinari P, Sloane DE, Samplaski M, Cosman D et al. Activation of human peripheral blood eosinophils through leukocyte immunoglobulin-like receptor 7. Proc Natl Acad Sci USA 2003;100: 11741179.
  • 61
    Munday J, Kerr S, Ni J, Cornish AL, Zhang JQ, Nicoll G et al. Identification characterization and leucocyte expression of siglec-10 a novel human sialic acid-binding receptor. Biochem J 2001;355: 489497.
  • 62
    Paul SP, Taylor LS, Stansbury EK, Mcvicar DW. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 96: 483490.
  • 63
    Nutku E, Aizawa H, Hudson SH, Bochner BS. Ligation of siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 2003;101: 50145020.
  • 64
    Munitz A, Colonna M, Levi-Schaffer F. 2B4 (CD244) is expressed and functional on human peripheral blood eosinophils. J Allergy Clin Immunol 2003;111: S259.
  • 65
    Parolini S, Bottino C, Falco M, Augugliaro R, Giliani S, Franceschini R et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein–Barr virus-infected cells. J Exp Med 2000;192: 337346.
  • 66
    Nakajima H, Colonna M. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. Hum Immunol 2000;61: 3943.
  • 67
    Tangye SG, Lazetic S, Woolatt E, Sutherland GR, Lanier LL, Phillips JH. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 1999;162: 69816985.
  • 68
    Kamata T, Yamashita M, Kimura M, Murata K, Inami M, Shimizu C et al. src homology 2 domain-containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation. J Clin Invest 2003;111: 109119.